πŸ‡ΊπŸ‡Έ FDA
Patent

US 11926830

Modulators of Complement Factor B

granted A61PA61P13/00A61P13/12

Quick answer

US patent 11926830 (Modulators of Complement Factor B) held by Ionis Pharmaceuticals, Inc. expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P13/00, A61P13/12, A61P27/02, A61P43/00